Nori Health
Digital therapeutics (DTx) for people living with inflammatory conditions, starting with Crohn's Disease and colitis.
Digital therapeutics (DTx) for people living with inflammatory conditions, starting with Crohn's Disease and colitis.
Nori, a startup based in The Netherlands, was founded in 2017 with a mission to provide digital therapeutics (DTx) for individuals living with inflammatory conditions, beginning with Crohn's Disease and colitis. The company's slogan reflects its commitment to leveraging digital products to offer personalized support for individuals managing chronic diseases. In its last investment round on 13 December 2021, Nori secured an $845.00K Seed Round investment from PharmStars and Healthy.Capital. Nori operates within the AI, Health Care, and Messaging and Telecommunications sectors, recognizing the growing need for ongoing support between doctor's visits for individuals with chronic conditions. The company aims to address the lack of personalized support and empower individuals to make lifestyle and behavioral changes, ultimately improving their quality of life.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $845.00K | 2 |
|
13 Dec 2021 |
| Pre Seed Round | €600.00K | - | 16 May 2019 | |
| Grant | $60.00K | 1 |
|
01 Dec 2017 |
No recent news or press coverage available for Nori Health.
We care about your data, and we'd love to use cookies make your experience better.
